216 related articles for article (PubMed ID: 34759881)
1. Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency Disorder.
Chin RF; Mingorance A; Ruban-Fell B; Newell I; Evans J; Vyas K; Nortvedt C; Amin S
Front Neurol; 2021; 12():734612. PubMed ID: 34759881
[No Abstract] [Full Text] [Related]
2. Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex.
Amin S; Ruban-Fell B; Newell I; Evans J; Vyas K; Nortvedt C; Chin RF
Orphanet J Rare Dis; 2024 Feb; 19(1):89. PubMed ID: 38409029
[TBL] [Abstract][Full Text] [Related]
3. Nordic treatment guidelines for rare epileptic conditions: A literature review.
Vyas K; Luedke H; Ruban-Fell B
Brain Behav; 2022 Jul; 12(7):e2622. PubMed ID: 35765698
[TBL] [Abstract][Full Text] [Related]
4. Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome.
Lo SH; Lloyd A; Marshall J; Vyas K
Clin Ther; 2021 Nov; 43(11):1861-1876.e16. PubMed ID: 34774333
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. A systematic literature review on the global epidemiology of Dravet syndrome and Lennox-Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality.
Sullivan J; Benítez A; Roth J; Andrews JS; Shah D; Butcher E; Jones A; Cross JH
Epilepsia; 2024 May; 65(5):1240-1263. PubMed ID: 38252068
[TBL] [Abstract][Full Text] [Related]
7. The impact of seizure frequency on quality of life in patients with Lennox-Gastaut syndrome or Dravet syndrome.
Auvin S; Damera V; Martin M; Holland R; Simontacchi K; Saich A
Epilepsy Behav; 2021 Oct; 123():108239. PubMed ID: 34375802
[TBL] [Abstract][Full Text] [Related]
8. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
[TBL] [Abstract][Full Text] [Related]
9. A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA).
Hahn CD; Jiang Y; Villanueva V; Zolnowska M; Arkilo D; Hsiao S; Asgharnejad M; Dlugos D
Epilepsia; 2022 Oct; 63(10):2671-2683. PubMed ID: 35841234
[TBL] [Abstract][Full Text] [Related]
10. Few individuals with Lennox-Gastaut syndrome have autism spectrum disorder: a comparison with Dravet syndrome.
He N; Li BM; Li ZX; Wang J; Liu XR; Meng H; Tang B; Bian WJ; Shi YW; Liao WP
J Neurodev Disord; 2018 Mar; 10(1):10. PubMed ID: 29558884
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
[TBL] [Abstract][Full Text] [Related]
12. Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.
Amin S; Møller RS; Aledo-Serrano A; Arzimanoglou A; Bager P; Jóźwiak S; Kluger GJ; López-Cabeza S; Nabbout R; Partridge CA; Schubert-Bast S; Specchio N; Kälviäinen R
Epilepsia Open; 2024 Jun; 9(3):832-849. PubMed ID: 38450883
[TBL] [Abstract][Full Text] [Related]
13. Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome.
Nabbout R; Arzimanoglou A; Auvin S; Berquin P; Desurkar A; Fuller D; Nortvedt C; Pulitano P; Rosati A; Soto V; Villanueva V; Cross JH
Seizure; 2023 Aug; 110():78-85. PubMed ID: 37331197
[TBL] [Abstract][Full Text] [Related]
14. The burden of illness in Lennox-Gastaut syndrome: a systematic literature review.
Strzelczyk A; Zuberi SM; Striano P; Rosenow F; Schubert-Bast S
Orphanet J Rare Dis; 2023 Mar; 18(1):42. PubMed ID: 36859290
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Wijnen B; Armstrong N; Ramaekers B; Witlox W; Westwood M; Fayter D; Ryder S; Buksnys T; Worthy G; Misso K; Grimm S; Kleijnen J; Joore M
Pharmacoeconomics; 2020 Oct; 38(10):1043-1053. PubMed ID: 32514751
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea.
Koo CM; Kim SH; Lee JS; Park BJ; Lee HK; Kim HD; Kang HC
J Korean Med Sci; 2020 Dec; 35(50):e427. PubMed ID: 33372424
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
García-Peñas JJ; Gil Nagel-Rein A; Sánchez-Carpintero R; Villanueva-Haba V
Rev Neurol; 2021 Sep; 73(S01):S1-S8. PubMed ID: 34486101
[TBL] [Abstract][Full Text] [Related]
18. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes.
Chen JW; Borgelt LM; Blackmer AB
Ann Pharmacother; 2019 Jun; 53(6):603-611. PubMed ID: 30616356
[TBL] [Abstract][Full Text] [Related]
20. Real-world use of the updated refractory epilepsy screening tool for Lennox-Gastaut syndrome.
Wolf SM; Boyce D; Peña P; Piña-Garza JE; Roland JJ; Thomas B; Zogejani D; McGoldrick PE
Epilepsia Open; 2024 May; ():. PubMed ID: 38726917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
